Meeting
2022 ASCO Genitourinary Cancers Symposium
Correlation of the rate of metastasis-free survival with the presence of pathogenic germline genetic mutations in patients with prostate cancer at a community practice.
Authors
Siddharth Ramanathan
Oakland University William Beaumont School of Medicine, Bloomfield Hills, MI
Siddharth Ramanathan , Sadhna Ramanathan , Alvaro Martinez , Andrew Korman , Michael Ghilezan , Michael Levin , Zachary Alan Gerndt , Nathan Shen , Kirk Wojno , Howard Korman , Savitha Balaraman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 70)
DOI
10.1200/JCO.2022.40.6_suppl.070
Abstract #
70
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Socio-demographic, clinical, and genetic predictors of low versus high Gleason score among men with prostate cancer in the Detroit Research on Cancer Survivorship (ROCS) cohort.
First Author: Samantha Goodenow
Poster
2023 ASCO Genitourinary Cancers Symposium
Germline DNA damage response (DDR) mutations in an East Asian (EA) cohort with prostate cancer (PCa).
First Author: Joanne Y.H. Lua
Poster
2018 Genitourinary Cancers Symposium
Germline pathologic mutations and cancer family history in prostate cancer patients.
First Author: Marcus Marie Moses
Poster
2023 ASCO Genitourinary Cancers Symposium
Germline testing for men with prostate cancer: Need to broaden the indications in Europe?
First Author: Elena Trevisi